Skip to main content
Boule Diagnostics logo

Boule Diagnostics — Investor Relations & Filings

Ticker · BOUL ISIN · SE0011231158 LEI · 213800IK1TGY858TKZ45 ST Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2022-10-03 AGM Information
Country SE Sweden
Listing ST BOUL

About Boule Diagnostics

https://boule.com/

Boule Diagnostics is a global provider of diagnostic solutions specializing in hematology. The company develops, manufactures, and markets systems and consumables for blood diagnostics, including hematology analyzers, clinical chemistry analyzers, and associated reagents, controls, and calibrators. Its products are tailored for decentralized healthcare settings in both the human and veterinary markets, such as smaller laboratories and clinics. The company aims to enhance global healthcare access by providing high-quality instruments that deliver timely and accurate blood test results.

Recent filings

Filing Released Lang Actions
KALLELSE TILL EXTRA BOLAGSSTÄMMA I BOULE DIAGNOSTICS AB
AGM Information Classification · 1% confidence The document is titled "KALLELSE TILL EXTRA BOLAGSSTÄMMA I BOULE DIAGNOSTICS AB" which translates to "NOTICE TO AN EXTRAORDINARY GENERAL MEETING IN BOULE DIAGNOSTICS AB". It details the date, location, registration procedures, agenda items (including proposals for amending the articles of association, approving a rights issue, and electing a new board member), and voting requirements for an Extraordinary General Meeting (EGM). This content perfectly matches the description of materials shared for a general meeting, specifically an EGM, which falls under the scope of AGM Information (AGM-R), even though it is an 'Extra' meeting, as it concerns shareholder governance and meeting procedures.
2022-10-03 Swedish
Boule Diagnostics beslutar om en fullt säkerställd företrädesemission om cirka 150 MSEK
Share Issue/Capital Change Classification · 1% confidence The document is a press release from Boule Diagnostics AB dated October 3, 2022, announcing a fully secured rights issue ('företrädesemission') of approximately 150 MSEK. The content details the purpose (financing development and commercialization), the terms (subscription price, ratio, discount), shareholder commitments, guarantee arrangements, and a preliminary timeline for the capital raise, including an upcoming Extraordinary General Meeting (EGM) to approve it. This clearly falls under the category of updates on company fundraising, financing activities, or capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-10-03 Swedish
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document details a change in shareholding and voting rights for a specific holder ('Keel Capital') in an issuer ('Boule Diagnostic AB'). It explicitly shows the 'Before the transaction' and 'After the transaction' quantities, including the resulting percentage of voting rights (5.05%) and the number of shares (1,009,054). This structure is characteristic of a notification regarding a change in significant share ownership, which aligns with the definition for Major Shareholding Notification (MRQ). The document is short and appears to be a regulatory filing reporting this specific event.
2022-09-07 English
CFO Annette Colin lämnar Boule av familjeskäl
Board/Management Information Classification · 1% confidence The document text is a short announcement stating that the CFO, Annette Colin, is leaving Boule Diagnostics due to family reasons and that the process to recruit a new CFO will begin immediately. This directly concerns a change in senior management. Based on the definitions, this aligns perfectly with the 'Board/Management Information' category (Code: MANG). The document is short and is an announcement, not a detailed report, confirming it is not an ER, IR, or 10-K.
2022-08-04 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for the period January–June 2022. It contains detailed financial statements, including income statements, balance sheet data, and management commentary on performance, regional sales, and operational developments. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-07-18 Swedish
Kommuniké från Boule Diagnostics AB:s årsstämma den 5 maj 2022
AGM Information Classification · 1% confidence The document is explicitly titled "Kommuniké från Boule Diagnostics AB:s årsstämma den 5 maj 2022" (Communication from Boule Diagnostics AB's Annual General Meeting on May 5, 2022). It details the decisions made at the AGM, such as approving financial statements, declaring dividends, electing the board, and approving remuneration and capital structure proposals. This content directly corresponds to the definition of AGM Information.
2022-05-05 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.